Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Intern Emerg Med ; 17(7): 2093-2101, 2022 10.
Article in English | MEDLINE | ID: mdl-35733074

ABSTRACT

To test the prognostic performance of different scores, both specifically designed for patients with COVID-19 and generic, in predicting in-hospital mortality and the need for mechanical ventilation (MV). We retrospectively collected clinical data of patients admitted to the Emergency Department of the University Hospital AOU Careggi, Florence, Italy, between February 2020 and January 2021, with a confirmed infection by SARS-CoV2. We calculated the following scores: Sequential Organ Failure Assessment (SOFA) score, CALL score, 4C Mortality score, QUICK score, CURB-65 and MuLBSTA score. The end-points were in-hospital mortality and the need for MV. We included 1208 patients, mean age 60 ± 17 years, 57% male sex. Compared to survivors, non-survivors showed significantly higher values of all the prognostic scores (4C: 13 [10-15] vs 8 [4-10]; CALL: 11 [10-12] vs 9 [7-11]; QUICK: 4 [1-6] vs 0 [0-3]; SOFA: 5 [4-6] vs 4 [4-5]; CURB: 2 [1-3] vs 1 [0-1]; MuLBSTA: 11 [9-13] vs 9 [7-11], all p < 0.001). Discriminative ability evaluated by the Receiver Operating Curve analysis showed the following values of the Area under the Curve: 0.83 for 4C, 0.74 for CALL, 0.70 for QUICK, 0.68 for SOFA, 0.76 for CURB and 0.64 for MuLBSTA. The mortality rate significantly increased in increasing quartiles of 4C and CALL score (respectively, 2, 8, 24 and 54% for the 4C score and 1, 17, 33 and 68% for the CALL score, both p < 0.001). 4C and CALL score allowed an early and good prognostic stratification of patients admitted for pneumonia induced by SARS-CoV2.


Subject(s)
COVID-19 , Pandemics , Adult , Aged , COVID-19/diagnosis , COVID-19/epidemiology , Female , Hospital Mortality , Humans , Intensive Care Units , Male , Middle Aged , Prognosis , RNA, Viral , ROC Curve , Retrospective Studies , SARS-CoV-2
2.
J Food Prot ; 69(11): 2703-11, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17133815

ABSTRACT

The effectiveness of a formulated product of the yeast Candida sake CPA-1 for controlling postharvest diseases on pome fruits was demonstrated in laboratory, semicommercial, and commercial trials carried out in the major pome fruit producing region of the European Union. First, one wettable powder and seven liquid formulations were tested in laboratory trials that involved two varieties of apples and two varieties of pears. In all cases, an efficacy similar to that of fresh cells was demonstrated in the control of artificial Penicillium expansum infection. After these trials, the formulated product chosen for semicommercial and commercial trials was LF1, a liquid formulation that is particularly suitable for commercial applications. In semicommercial trials, LF1 showed a performance similar to fresh cells in most trials, and the population dynamics of both fresh and formulated cells were quite stable throughout the storage period. This indicates the high viability of C. sake CPA-1 in this formulation and the absence of adverse effects during the formulation of the product, which may significantly affect both its ability to grow on fruit and its antagonistic activity. We evaluated the control of natural infection after applying the formulated product in a commercial drencher in different packinghouses. A significant reduction in the incidence of diseases was observed with a recommended dose of around 10(7) CFU/ml when natural infections were greater than 1%. In general, large quantities of yeast were observed on the surface of unwounded fruits of different pome fruit cultivars. Moreover, populations of this biocontrol agent increased rapidly on fruit surfaces and remained quite stable for a long time under commercial storage conditions. Commercial practices used in packinghouses were therefore successfully applied for this formulated product.


Subject(s)
Candida/physiology , Food Preservation/methods , Fruit/microbiology , Penicillium/growth & development , Pest Control, Biological , Antibiosis , Colony Count, Microbial , Food Microbiology , Fruit/standards , Mediterranean Region
3.
Radiat Prot Dosimetry ; 115(1-4): 187-94, 2005.
Article in English | MEDLINE | ID: mdl-16381710

ABSTRACT

The TRADE project (TRiga Accelerator Driven Experiment), to be performed at the existing TRIGA reactor at ENEA Casaccia, has been proposed as a validation of the accelerator-driven system (ADS) concept. TRADE will be the first experiment in which the three main components of an ADS--the accelerator, spallation target and sub-critical blanket--are coupled at a power level sufficient to encounter reactivity feedback effects. As such, TRADE represents the necessary intermediate step in the development of hybrid transmutation systems, its expected outcomes being considered crucial--in terms of proof of stability of operation, dynamic behaviour and licensing issues--for the subsequent realisation of an ADS Transmutation Demonstrator. An essential role in the feasibility study of the experiment is played by radioprotection calculations. Such a system exhibits new characteristics with respect to a traditional reactor, owing to the presence of the proton accelerator. As beam losses always occur under normal operating conditions of an accelerator, shielding studies need to be performed not only around the reactor but also along the beam line from the accelerator to the spallation target. This paper illustrates a preliminary evaluation, using Monte Carlo methods, of the additional shielding to be located around the reactor structures, the beam transport line and the existing reactor building to allow access into the reactor hall and to restrict the doses outside to their legal limits.


Subject(s)
Computer-Aided Design , Facility Design and Construction/methods , Particle Accelerators/instrumentation , Radiation Monitoring/methods , Radiation Protection/instrumentation , Radiation Protection/methods , Synchrotrons/instrumentation , Computer Simulation , Equipment Design/methods , Equipment Failure Analysis/methods , Facility Design and Construction/instrumentation , Gamma Rays , Models, Theoretical , Neutrons , Radiation Dosage , Risk Assessment/methods , Risk Factors
4.
Radiat Prot Dosimetry ; 116(1-4 Pt 2): 475-81, 2005.
Article in English | MEDLINE | ID: mdl-16604681

ABSTRACT

An epithermal boron neutron capture therapy facility for treating brain gliomas is currently under construction at the 5 kW fast-flux reactor TAPIRO located at ENEA, Casaccia, near Rome. In this work, the sensitivity of the results to the boron concentrations in healthy tissue and tumour is investigated and the change in beam quality on modifying the moderator thickness (within design limits) is studied. The Monte Carlo codes MCNP and MCNPX were used together with the DSA in-house variance reduction patch. Both usual free beam parameters and the in-phantom treatment planning figures-of-merit have been calculated in a realistic anthropomorphic phantom ('ADAM').


Subject(s)
Boron Neutron Capture Therapy/methods , Brain Neoplasms/radiotherapy , Glioma/radiotherapy , Models, Biological , Radiometry/methods , Radiotherapy Planning, Computer-Assisted/methods , Boron Neutron Capture Therapy/instrumentation , Computer Simulation , Humans , Italy , Monte Carlo Method , Nuclear Reactors/instrumentation , Radiotherapy Dosage , Treatment Outcome
5.
Appl Radiat Isot ; 61(5): 987-91, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15308180

ABSTRACT

An epithermal facility for treating patients with brain gliomas has been designed and is under construction at the fast reactor TAPIRO at ENEA Casaccia (Italy). The calculational design tools employed were the Monte Carlo codes MCNP/MCNPX together with the DSA in-house variance reduction patch. A realistic anthropomorphic phantom ("ADAM") was included to optimise dose profiles and in-phantom treatment-planning figures-of-merit. The adopted approach was to minimise the treatment time whilst maintaining a reasonable therapeutic ratio. It is shown that TAPIRO, in spite of its low power of 5 kW, is able to provide an epithermal beam that is of good quality and of sufficient intensity to allow a single beam patient irradiation, under conservative assumptions, of 50 min.


Subject(s)
Boron Neutron Capture Therapy/instrumentation , Brain Neoplasms/radiotherapy , Glioma/radiotherapy , Boron Neutron Capture Therapy/statistics & numerical data , Humans , Italy , Monte Carlo Method , Phantoms, Imaging , Radiotherapy Planning, Computer-Assisted/instrumentation , Radiotherapy Planning, Computer-Assisted/statistics & numerical data
6.
Plant Dis ; 83(8): 773-776, 1999 Aug.
Article in English | MEDLINE | ID: mdl-30845567

ABSTRACT

The effects of different concentrations of peracetic acid (PAA; 62.5, 125, 250, 500, and 1,000 µg/ml)and chlorine dioxide (ClO2; 12.5, 25, 50, 100, and 200 µg/ml) on germination of Monilinia laxa conidia were tested. Conidia germination was related to the concentration of chemical product used, as well as duration of treatment. Complete inhibition of germination was observed with PAA at 500 µg/ml after 5 min of contact with conidia and with ClO2 at 50 µg/ml after 1 min of contact with conidia. The results of in vitro tests were confirmed by inoculation of fruits with treated conidia. The PAA treatment also was effective 1 h after pathogen inoculation but only on plums, for which a 1,000 µg/ml treatment significantly reduced decay incidence by 50%. In a semi-commercial test, pathogen conidia dipped for 20 min in PAA at 250 µg/ml or ClO2 at 10 µg/ml or for 5 min in PAA at 250 µg/ml were completely inhibited, and no brown rot was observed in inoculated wounded nectarines and plums.

SELECTION OF CITATIONS
SEARCH DETAIL